BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35287689)

  • 1. PSMC2 is overexpressed in glioma and promotes proliferation and anti-apoptosis of glioma cells.
    Zheng X; Wang Y; Wang D; Wan J; Qin X; Mu Z; Hu N
    World J Surg Oncol; 2022 Mar; 20(1):84. PubMed ID: 35287689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of Proteasome 26S Subunit ATPase 2 Regulates Colorectal Cancer Cell Proliferation, Apoptosis, and Migration.
    He J; Xing J; Yang X; Zhang C; Zhang Y; Wang H; Xu X; Wang H; Cao Y; Xu H; Zhang C; Wang C; Yu E
    Chemotherapy; 2019; 64(3):146-154. PubMed ID: 31715603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of PSMC2 contributes to suppression of cholangiocarcinoma development by regulating CDK1.
    Duan X; Yang J; Jiang B; Duan W; Wei R; Zhang H; Mao X
    Aging (Albany NY); 2021 Sep; 13(17):21325-21344. PubMed ID: 34499615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSMC2/CCND1 axis promotes development of ovarian cancer through regulating cell growth, apoptosis and migration.
    Zhu D; Huang J; Liu N; Li W; Yan L
    Cell Death Dis; 2021 Jul; 12(8):730. PubMed ID: 34294689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSMC2 is up-regulated in osteosarcoma and regulates osteosarcoma cell proliferation, apoptosis and migration.
    Song M; Wang Y; Zhang Z; Wang S
    Oncotarget; 2017 Jan; 8(1):933-953. PubMed ID: 27888613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
    Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
    Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower miR-630 expression predicts poor prognosis of osteosarcoma and promotes cell proliferation, migration and invasion by targeting PSMC2.
    Li GW; Yan X
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1915-1925. PubMed ID: 30915734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU).
    Wang Y; Zhu M; Li J; Xiong Y; Wang J; Jing H; Gu Y
    Cell Death Dis; 2021 Jul; 12(7):690. PubMed ID: 34244472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSMC2 promotes glioma progression by regulating immune microenvironment and PI3K/AKT/mTOR pathway.
    Wang Y; Zhang S; Zhao Z; Jin Q; Wang Z; Song Z; Liu L; Zhao Z
    Immunobiology; 2024 May; 229(3):152802. PubMed ID: 38569452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSMC2 knockdown exerts an anti-tumor role in nasopharyngeal carcinoma through regulating AKT signaling pathway.
    Su J; Hu S; Ding S; Feng K
    Cell Cycle; 2023 Nov; 22(21-22):2381-2391. PubMed ID: 38123344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
    Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
    J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key genes and functions of circulating tumor cells in multiple cancers through bioinformatic analysis.
    Guan Y; Xu F; Wang Y; Tian J; Wan Z; Wang Z; Chong T
    BMC Med Genomics; 2020 Sep; 13(1):140. PubMed ID: 32972417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
    Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
    Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of HOXC10 gene on biological behaviors of glioma cells and mechanism in tumor microenvironment].
    Jiang WY; Lei QY; Liu SS; Yang L; Yang B; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):228-237. PubMed ID: 35316872
    [No Abstract]   [Full Text] [Related]  

  • 15. Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration.
    Chen Q; Fu L; Hu J; Guo G; Xie A
    Cancer Cell Int; 2021 Apr; 21(1):235. PubMed ID: 33902600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of Long Non-Coding RNA (LncRNA) Non-Coding RNA Activated by DNA Damage (NORAD) Inhibits Proliferation, Invasion, Migration, and Promotes Apoptosis of Glioma Cells via Downregulating the Expression of AKR1B1.
    Luo L; Chen C; He H; Cai M; Ling C
    Med Sci Monit; 2020 Jul; 26():e922659. PubMed ID: 32778640
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Qin J; Wang W; An F; Huang W; Ding J
    J Cancer; 2019; 10(20):4939-4946. PubMed ID: 31598166
    [No Abstract]   [Full Text] [Related]  

  • 18. PSMC2 knockdown suppressed tumor progression of skin cutaneous melanoma.
    Yang Y; Qi F; Wei C; Liu J; Zhang Y; Luan W; Gu J
    Cell Death Discov; 2021 Oct; 7(1):323. PubMed ID: 34716318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Silence of PSMC6 Inhibits Cell Growth and Metastasis in Lung Adenocarcinoma.
    Zhang JY; Shi KZ; Liao XY; Li SJ; Bao D; Qian Y; Li DJ
    Biomed Res Int; 2021; 2021():9922185. PubMed ID: 34239933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of PSMC2 promotes gallbladder cancer through regulation of GNG4 and predicts poor prognosis.
    Zhu D; Gu X; Lin Z; Yu D; Wang J
    Oncogenesis; 2021 May; 10(5):43. PubMed ID: 34016944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.